Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib treatment for hair loss may worsen acne.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.